Phase 1 — Benign Prostatic Hyperplasia (BPH)

The purpose of this study is to evaluate the safety and effectiveness of using Aptocine in patients with LUTS due to benign prostatic hyperplasia.

For more information about this trial, please visit the trial registration page at ClinicalTrials.gov:

Go to ClinicalTrials.gov, Trial ID # NCT00709488